Overview
Status
Active
Registry date
2017-08-10
Share capital
4 600 000,00 PLN
Registered address
ul. Muchoborska 6, 54-424 Wrocław, Poland
Electronic delivery address
AE:PL-85323-51247-HAVCR-28
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 165.97kMedianUSD 109.30kAverageUSD 2.05m
Net profit
This companyUSD -353.40kMedianUSD -146.00AverageUSD 64.37k
Operating costs
This companyUSD 338.79kMedianUSD 161.19kAverageUSD 1.91m
Assets
This companyUSD 482.46kMedianUSD 124.37kAverageUSD 1.42m
Industry
Bank accounts
Registered as a VAT taxpayer on 2017-08-21. Active
97 1090 1522 0000 0001 3489 5728
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
5 public aid cases recorded, with a total value of $421,862.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 20, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Starosta Karkonoski | |
| Jul 30, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Wrocławski Park Technologiczny S.A. | |
| Jul 20, 2018 | Aid for research and development projects: industrial research | –– | Marszałek Dolnośląski |
Tenders
No recorded participation in tenders.
Trademarks
Pharmfactor holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2018.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Piotr Adam Kuriata – Liquidator
Supervisory board
Andrzej Kuchar – Supervisory Board Member
Karolina Beata Kuchar – Supervisory Board Member
Oliwia Kuchar – Supervisory Board Member
Ownership
| Owner | Shares | Stake |
|---|---|---|
Biomedycyna Polska S.A. | 1,980 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Ewa Katarzyna Andreasik Kuchar (72) | Posiada 30% udziałów w spółce dcdg sp. z o.o., posiadającej 100% akcji w spółce biomedycyna polska s.a., która posiada 99% udziałów w zgłaszanej spółce pharmfactor sp. z o.o. | |
Andrzej Kuchar (76) | Posiada 39,93% udziałów w spółce dcdg sp. z o.o., posiadającej 100% akcji w spółce biomedycyna polska s.a., która posiada 99% udziałów w zgłaszanej spółce pharmfactor sp. z o.o. | |
Tomasz Kuchar (50) | Posiada 30% udziałów w spółce dcdg sp. z o.o., posiadającej 100% akcji w spółce biomedycyna polska s.a., która posiada 99% udziałów w zgłaszanej spółce pharmfactor sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-19 | Name change (Pharmfactor → Pharmfactor Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2026-07-16 | Liquidation opened | |
| 2020-12-16 | Share capital change (100,000.00 PLN → 4,600,000.00 PLN) | |
| 2020-02-14 | Share capital change (5,000.00 PLN → 100,000.00 PLN) | |
| 2017-08-10 | Entered in the register |
FAQ
The main business activity of Pharmfactor focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on August 10, 2017.
The headquarters is located at: ul. Muchoborska 6, 54-424 Wrocław.
The share capital of the company is PLN 4,600,000 (approx. $1.2 million).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 165,972 in 2025, which is a decrease of 82.6% compared to 2024.
No, in 2025 the company reported a net loss of USD 353,405.
The largest operating cost category falls under external services. This category amounted to USD 141,427 in 2025, representing 42% of all operating expenses.
Last updated: 2026-08-19